What is CVE-2018-12234?

CVE-2018-12234 is a medium-severity vulnerability in Myadrenalin Adrenalin, classified under Cross-site Scripting. CVSS score: 6.1/10. Published 2018-09-06.

How severe is CVE-2018-12234?

Medium severity. CVSS v3 base score is 6.1 out of 10.

XSS in Myadrenalin Adrenalin

CVE-2018-12234

A Reflected Cross Site Scripting (XSS) Vulnerability was discovered in Adrenalin 5.4.0 HRMS Software. The user supplied input containing JavaScript is echoed back in JavaScript code in an HTML response via the flexiportal/GeneralInfo.aspx strAction parameter.

Vulnerability class: XSS (Cross-Site Scripting)

EPSS: 0.029 (85.7th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 6.1 (Medium). Vector: CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N.

Affected products

Myadrenalin Adrenalin — versions 5.4.0
N/a — versions n/a

Weakness classification (CWE)

CWE-79 — Cross-site Scripting

References

cve@mitre.org (Exploit, Third Party Advisory)
cve@mitre.org
cve@mitre.org (URL Repurposed)
cve@mitre.org

Frequently asked questions

What is CVE-2018-12234?: CVE-2018-12234 is a medium-severity vulnerability in Myadrenalin Adrenalin, classified under Cross-site Scripting. CVSS score: 6.1/10. Published 2018-09-06.
How severe is CVE-2018-12234?: Medium severity. CVSS v3 base score is 6.1 out of 10.